1-1 of 1
Kevin Quann
Close
Sort by
Journal Articles

Natalizumab for GVHD: too little or too late?

Clinical Trials & Observations
Kevin Quann, Faruk Sacirbegovic, Warren D. Shlomchik
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5187–5188.
https://doi.org/10.1182/bloodadvances.2023010486
Published: 2023